ArticleHaematologica2025

Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile.

Paul Richardson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.